New England Research & Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,238
Closed -$1.39M 159
2022
Q1
$1.39M Sell
24,238
-14,900
-38% -$762K 0.72% 46
2021
Q4
$1.85M Buy
39,138
+4,880
+14% +$222K 0.89% 34
2021
Q3
$1.44M Buy
34,258
+11,555
+51% +$500K 0.76% 43
2021
Q2
$1.01M Buy
+22,703
New +$1.05M 0.52% 69
2020
Q4
Sell
-13,273
Closed -$382K 156
2020
Q3
$382K Buy
+13,273
New +$374K 0.28% 94

Other funds holding CTVA

New England Research & Management's CTVA Position: Q2 2022 in Review

New England Research & Management sold out of Corteva (CTVA) in Q2 2022, closing a stake of 24,238 shares — an estimated $1.39M sold.

New England Research & Management first reported a position in CTVA in Q3 2020 and held it in 5 quarters. The position peaked at $1.85M in Q4 2021. 1,191 funds tracked by Wall St. Rank hold CTVA as of Q2 2022.

  • New England Research & Management reported no remaining Corteva position as of Q2 2022 after selling out during the quarter.
  • New England Research & Management sold 24,238 Corteva shares in Q2 2022, an estimated $1.39M.
  • New England Research & Management first reported a position in Corteva in Q3 2020 and held it in 5 quarters.
  • New England Research & Management's Corteva position peaked at $1.85M in Q4 2021.
  • 1,191 funds tracked by Wall St. Rank held Corteva as of Q2 2022.

Based on New England Research & Management's 13F filing for Q2 2022, filed 20 Jul 2022.